Pepsinogen I Pepsinogen II iyo Gastrin-17 Combo xirmada tijaabada degdega ah
Qalabka ogaanshaha ee Pepsinogen I/Pepsinogen II /Gastrin-17
Habka: Baaritaanka immunochromatographic fluorescence
Macluumaadka wax soo saarka
Nambarka Model | G17/PGI/PGII | Baakad | 25 Tijaabooyin/xirmo, 30kits/CTN |
Magaca | Qalabka ogaanshaha ee Pepsinogen I/Pepsinogen II /Gastrin-17 | Kala soocidda qalabka | Fasalka II |
Astaamaha | Dareen sare, hawl fudud | Shahaado | CE/ ISO13485 |
Saxnaanta | > 99% | Nolosha shelf | Laba Sano |
Habka | Fluorescence immunochromatographic qiimaynta | OEM/ODM adeegga | La heli karo |
ISTICMAALKA KULA JIRA
Qalabkan ayaa lagu dabaqi karaa ogaanshaha in vitro ee cabbiraadda uruurinta Pepsinogen I (PGI), Pepsinogen II
(PGII) iyo Gastrin 17 ee serum/plasma/muunadaha dhiiga oo dhan, si loo qiimeeyo unugyada qanjidhada oksintic gastric
shaqada, dhaawaca fundus gastric fundus xuubka xuubka iyo gastritis atrophic. Qalabku wuxuu bixiyaa natiijada tijaabada Pepsinogen I
(PGI), Pepsinogen II (PGII) iyo Gastrin 17. Natiijada la helay waa in lagu falanqeeyaa iyadoo lagu darayo bukaanno kale
xog. Waa inay isticmaalaan kaliya xirfadlayaasha daryeelka caafimaadka.
Habka tijaabada
1 | Kahor intaadan isticmaalin reagent, si taxadar leh u akhri galka xirmada oo baro hababka qalliinka. |
2 | Dooro qaabka tijaabada caadiga ah ee WIZ-A101 falanqeeyaha difaaca ee la qaadan karo. |
3 | Fur xirmada bacda bireed aluminium ee reagent oo soo saar qalabka tijaabada. |
4 | Si toos ah u geli aaladda tijaabada godka falanqeeyaha difaaca. |
5 | Bogga guriga ee interface interface ee falanqeeyaha difaaca, dhagsii "Standard" si aad u gasho interface interface |
6 | Guji "QC Scan" si aad u sawirto koodka QR ee dhinaca gudaha ee qalabka; xirmada gelinta ee laxiriirta cabirrada qalabka iyo dooro nooca muunada. Xusuusin: Nambar kasta oo xirmada ka mid ah waa in la sawiraa hal mar. Haddii lambarka dufcada la sawiray, markaa ka gudub talaabadan. |
7 | Hubi joogteynta "Magaca Alaabta", "Lambarka Dufcada" iwm. On interface ka tijaabada macluumaadka qalabka sumadda. |
8 | Ka dib marka la xaqiijiyo in xogta ay joogto tahay, qaado muunad dareereyaal ah, ku dar 80µL oo serum/balaasmas ah/dhiig dhan muunad, oo ku filan isku dar. |
9 | Ku dar 80µL oo ah xal isku dhafan oo sare ah godka muunada ee aaladda tijaabada. |
10 | Ka dib marka muunada la isku daro, dhagsii "Waqtiga" iyo wakhtiga tijaabada ee hadhay si toos ah ayaa loo soo bandhigi doonaa interface. |
11 | Falanqeeyaha difaaca ayaa si toos ah u dhamaystiri doona baaritaanka iyo falanqaynta marka wakhtiga tijaabada la gaaro. |
12 | Xisaabinta natiijada iyo muujinta Ka dib marka la dhammeeyo baaritaanka difaaca jirka, natiijada baaritaanka waxaa lagu soo bandhigi doonaa interface interface ama waa la arki karaa iyada oo loo marayo "Taariikhda" bogga guriga ee interface interface. |
Waxqabadka Caafimaadka
Waxqabadka qiimaynta bukaan-socodka ee badeecada waxa lagu qiimeeyaa iyadoo la ururinayo 200 oo muunado caafimaad ah. U isticmaal xirmada suuq-geynta ee enzym-ku-xiran immunosorbent assay sidii reagent-ka xakamaynta. Is barbar dhig natiijooyinka imtixaanka PGI. Isticmaal dib u celinta toosan si aad u baarto isbarbardhiggooda. Isku-xirnaanta labada imtixaan waa y = 0.964X + 10.382 iyo R=0.9763 siday u kala horreeyaan. Is barbar dhig natiijooyinka imtixaanka PGII Isticmaal dib u celinta toosan si aad u baarto isbarbardhiggooda. Isku-xirnaanta labada imtixaan waa y = 1.002X + 0.025 iyo R=0.9848 siday u kala horreeyaan. Is barbar dhig natiijooyinka baaritaanka G-17. Isticmaal dib u celinta toosan si aad u baarto isbarbardhiggooda. Isku-xirnaanta labada imtixaan waa y = 0.983X + 0.079 iyo R=0.9864 siday u kala horreeyaan.
Waxa kale oo aad jeclaan kartaa: